Related Experiment Video
Updated: Aug 8, 2025

Author Spotlight: Development and Evaluation of a Standardized Rat Model for Calvarial Suture-Bony Composite Defects
Published on: May 10, 2024
Biodegradable silk fibroin scaffold doped with mineralized collagen induces bone regeneration in rat cranial defects
1Tianjin Hospital, Tianjin University, No. 406 Jiefang South Road, Hexi District, Tianjin 300211, China; Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Neural Regeneration Co-Innovation Center of Jiangsu Province, Nantong University, No. 19 Qixiu Road, Chongchuan District, Nantong 226001, China; Senior Department of Orthopedics, Beijing Key Lab of Regenerative Medicine in Orthopedics, The 1th Medical Center of PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China.
Abstract:
Compared with most nondegradable or slowly degradable bone repair materials, bioactive biodegradable porous scaffolds with certain mechanical strengths can promote the regeneration of both new bone and vasculature while the cavity created by their degradation can be replaced by the infiltration of new bone tissue. Mineralized collagen (MC) is the basic structural unit of bone tissue, and silk fibroin (SF) is a natural polymer with adjustable degradation rates and superior mechanical properties. In this study, a three-dimensional porous biomimetic composite scaffold with a two-component SF-MC system was constructed based on the advantages of both materials. The spherical mineral agglomerates of the MC were uniformly distributed on the surface and inside the SF skeleton, which ensured good mechanical properties while regulating the degradation rate of the scaffold. Second, the SF-MC scaffold had good osteogenic induction of bone marrow mesenchymal stem cells (BMSCs) and preosteoblasts (MC3T3-E1) and also promoted the proliferation of MC3T3-E1 cells. Finally, in vivo 5 mm cranial defect repair experiments confirmed that the SF-MC scaffold stimulated vascular regeneration and promoted new bone regeneration in vivo by means of in situ regeneration. Overall, we believe that this low-cost biomimetic biodegradable SF-MC scaffold with many advantages has some clinical translation prospects.

